Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $15.42 million versus the consensus estimate of $17.13 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.